Use of recombinant P-glycoprotein fragments to produce antibodies to the multidrug transporter

https://doi.org/10.1016/0006-291X(90)91928-LGet rights and content

Abstract

Multidrug-resistance of human cancer cells may result from expression of a 170,000 dalton multidrug efflux pump called P-glycoprotein. To identify this multidrug transporter, and to study its structure and function, we have generated polyclonal rabbit antibodies against the aminoterminal and carboxy-terminal halves of the molecule using recombinant protein fragments produced in Escherichia coli. Two recombinant P-glycoprotein fragments, representing amino acids 140–228 and 919–1280, were overproduced in Escherchia coli by an inducible T7 expression system, gel-purified and injected into rabbits. Both antisera specifically immunoprecipitate 3H-azidopine and 35S-methionine labeled P-glycoprotein from multidrug-resistant cells and detect P-glycoprotein on Western blots with high sensitivity. Because these antisera were raised against epitopes in the amino-and carboxy-terminal halves of P-glycoprotein, they should be useful as research tools to define the function of these two halves of the molecule.

References (25)

  • M.M. Gottesman et al.

    J. Biol. Chem

    (1988)
  • C.-j. Chen et al.

    Cell

    (1986)
  • P. Gros et al.

    Cell

    (1986)
  • F.W. Studier et al.

    J. Mol. Biol

    (1986)
  • A.H. Rosenberg et al.

    Gene

    (1987)
  • A.R. Safa et al.

    J. Biol. Chem

    (1987)
  • U.A. Germann et al.

    J. Biol. Chem

    (1989)
  • R. Zeheb et al.

    Biochem. Biophy. Res. Commun

    (1987)
  • F. Thiebaut et al.
  • F. Thiebaut et al.

    J. Histochem. Cytochem

    (1989)
  • C. Cordon-Cardo et al.
  • L.J. Goldstein et al.

    J. Natl. Cancer Inst

    (1989)
  • Cited by (0)

    View full text